发明名称 |
COMPOUNDS AND METHODS OF TREATING OCULAR DISORDERS |
摘要 |
<p>Abstract: A method of treating an ocular disorder in a subject associated with aberrant all-trans-retinal clearance in the retina, the method comprising administering to the subject a therapeutically effective amount of a primary amine compound of formula: wherein R1 is an aliphatic and/or aromatic compound; the primary amine compound upon administration to the subject forming a reversible Schiff-base with the all-trans-retinal or its metabolite in-chiding A2E and retinal dimer without adversely affecting normal retinoid cycle performance; the primary amine compound when administered to a Rdh8-'- Abca4-,- mouse increasing the optical coherence tomography score of the mouse to at least about 2.5 and increasing II-ds-retinal amount at least about 30% in comparison to untreated control animal, wherein the primary amine compound is not a local anesthetic, which includes an aromatic amine, that demonstrates sodium channel blockade when administered to the subject. 2218156v1</p> |
申请公布号 |
AU2015201077(A1) |
申请公布日期 |
2015.03.19 |
申请号 |
AU20150201077 |
申请日期 |
2015.03.03 |
申请人 |
CASE WESTERN RESERVE UNIVERSITY |
发明人 |
PALCZEWSKI, KRZYSZTOF;MAEDA, AKIKO;GOLCZAK, MARCIN |
分类号 |
A61K9/20;A61K9/22;A61K31/4162;A61K31/4184;A61K31/428;A61K31/56;A61P27/02 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|